| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |